ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs ...
The Chosun Ilbo on MSN

Chong Kun Dang expands new drug pipeline via cell, gene therapies, ADCs

Chong Kun Dang announced last year a plan to invest 2.2 trillion Korean won in constructing a state-of-the-art ...
Fierce Pharma

Lonza expands partnership with US drugmaker, boosts capacity for ADCs

Contract manufacturing powerhouse Lonza is growing in more ways than one. | Contract manufacturing powerhouse Lonza is growing in more ways than one. The Swiss company revealed this week that it is ...
BioSpace

ADC Therapeutics lays off staff after 27 patient deaths mar Zynlonta readout

After 27 deaths were reported in a group receiving its blood cancer drug, ADC Therapeutics is downsizing, implementing ...

Inocras and AimedBio Partner to Advance Cancer Drug Discovery and Precision Oncology with Whole Genome Intelligence

Inocras Inc., a U.S.-based precision medicine company, today announced a strategic partnership with AimedBio, a South Korean biopharmaceutical company developing antibody-drug conjugates (ADCs) for ...
Fierce Biotech

Pfizer’s first new ADC from Seagen acquisition fails phase 3 NSCLC trial

Pfizer’s high-stakes bet on antibody-drug conjugates (ADCs) has hit a speed bump. | Pfizer announced Monday that sigvotatug ...
GEN - Genetic Engineering and Biotechnology News

Shilpa Commissions Integrated ADC Drug Substance GMP Manufacturing Facility

Shilpa Biologicals says India has the scientific talent and infrastructure to be a trusted partner in ADC drug substance manufacturing.